Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of H5N1 Vaccine GSK1557484A in Children
NCT01310413Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2011
- Primary completion
- Jul 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 3 trial of influenza A (Q-Pan H5N1) virus monovalent vaccine (A/Indonesia) in Influenza A H5N1 (H5N1), sponsored by GSK. Started Mar 2011; status: completed.
02
Drugs
influenza A (Q-Pan H5N1) virus monovalent vaccine (A/Indonesia)
03
Conditions
Influenza A H5N1 (H5N1)
Beyond the preview
Go deeper on NCT01310413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01310413.